NSAID and oesophageal adenocarcinoma: randomised trials needed to correct for bias.
Jankowski
Janusz
J
deCaestecker
John
J
Harrison
Rebecca
R
Watson
Peter
P
Barr
Hugh
H
Attwood
Stephen
S
Moayyedi
Paul
P
D000230:Adenocarcinoma / Q000209:etiology / Q000517:prevention & control*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001471:Barrett Esophagus / Q000150:complications* / Q000188:drug therapy; D004938:Esophageal Neoplasms / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results; D012107:Research Design; D012307:Risk Factors; D013534:Survival
D000894:Anti-Inflammatory Agents, Non-Steroidal